Corpus Intelligence IC Memo — HAWKINS COUNTY MEMORIAL HOSPITAL 2026-04-27 04:13 UTC
IC Memo — HAWKINS COUNTY MEMORIAL HOSPITAL
Investment Committee Memorandum | TN | 6 beds | Grade C | EBITDA uplift $1.0M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 440032

HAWKINS COUNTY MEMORIAL HOSPITAL

LOCATIONHAWKINS, TN·BEDS6·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

HAWKINS COUNTY MEMORIAL HOSPITAL is a 6-bed suburban community hospital in HAWKINS, TN with $13.7M in net patient revenue and a -8.4% operating margin. The hospital serves a payer mix of 21.2% Medicare, 2.8% Medicaid, and 76.0% commercial.

Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.4% to -1.0% (+737bps).

Net Revenue HCRIS$13.7M
Current EBITDA COMPUTED$-1.1M
Operating Margin COMPUTED-8.4%
Occupancy HCRIS47.3%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS18.3%
Distress Probability ML45.0%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
114
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -8.4% places it below the state median. Among 114 size-comparable peers (3-12 beds), the median margin is -8.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (3-12), prioritizing same-state peers. 114 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HAWKINS COUNTY MEMORIAL HOSPIT (Target)TN6$13.7M-8.4%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
FRANCISCAN HEALTH HAMMONDIN10$117.7M-4.3%
OCONTO HOSPITAL & MEDICAL CENTWI10$80.4M1.1%
SUMMIT PACIFIC MEDICAL CENTERWA10$73.6M9.1%
PHYSICIANS MEDICAL CENTERIN10$60.0M24.9%
SAMUEL SIMMONDS MEMORIAL HOSPIAK10$57.8M-50.0%
INSTITUTE FOR ORTHOPAEDIC SURGOH12$55.6M39.5%
JOYCE EISENBERG KEEFER MEDICALCA10$52.9M18.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$289K+210bp18mo
Cost to Collect4.5%2.5%$275K+200bp12mo
Denial Rate Reduction12.0%6.5%$273K+199bp12mo
A/R Days Reduction5200.0%3800.0%$167K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$289K
Cost to Collect
$275K
Denial Rate Reduction
$273K
A/R Days Reduction
$167K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.0M
Current EBITDA$-1.1M
+ RCM Uplift+$1.0M
Pro Forma EBITDA$-136K
Current Margin-8.4%
Pro Forma Margin-1.0%
WC Released (1x)$527K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.8M$2.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.8M$2.2M0.00x-100.0%
Bull Case9.0x11.0x$-1.6M$5.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.6M$5.0M0.00x-100.0%
Bear Case11.0x10.0x$-1.9M$-1.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.9M$-2.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 114 hospitals with 3-12 beds
  • Same-state prioritization (n=5)
  • Comp margins: P25=-22.5% / P50=-8.7% / P75=2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.